SEC Form 4 · accession 0001209191-15-049824
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly Manhard
Director
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | M | 2,708 | $9.05 | A | 2,708 | D | |
| Common Stock | Jun 1, 2015 | S | 2,708 | $21.17 | D | 0 | D | |
| Common Stock | Jun 2, 2015 | M | 10,500 | $8.80 | A | 10,500 | D | |
| Common Stock | Jun 2, 2015 | S | 10,500 | $23.58 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.05 | Jun 1, 2015 | M | 2,708 | D | — | Dec 12, 2024 | Common Stock | 2,708 | 16,292 | D |
| Stock Option (Right to Buy)F2 | $8.80 | Jun 2, 2015 | M | 10,500 | D | — | Jan 10, 2024 | Common Stock | 10,500 | 21,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the date of grant (12/12/2014).
- F2The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/10/2014).